Table 4.
Standardized mortality ratios (SMRs), underlying cause of death
| Underlying | Camp Pendleton (reference) | Camp Lejeune | ||||
|---|---|---|---|---|---|---|
| Cause of death |
Obs. |
Exp. |
SMR (95% CI) |
Obs. |
Exp. |
SMR (95% CI) |
| All causes |
9,365 |
10,922 |
0.86 (0.84, 0.87) |
8,964 |
10,864 |
0.83 (0.81, 0.84) |
| All cancers |
1,008 |
1,296 |
0.78 (0.73, 0.83) |
1,078 |
1,272 |
0.85 (0.80, 0.90) |
| Diseases of primary interest | ||||||
| Kidney cancer |
33 |
37.20 |
0.89 (0.61, 1.25) |
42 |
36.08 |
1.16 (0.84, 1.57) |
| Bladder cancer |
14 |
13.65 |
1.03 (0.56, 1.72) |
11 |
13.04 |
0.84 (0.42, 1.51) |
| Liver* cancer |
39 |
69.21 |
0.56 (0.40, 0.77) |
51 |
69.20 |
0.74 (0.55, 0.97) |
| Esophageal cancer |
27 |
43.33 |
0.62 (0.41, 0.91) |
35 |
41.34 |
0.85 (0.59, 1.18) |
| Hematopoietic cancers |
167 |
215.93 |
0.77 (0.66, 0.90) |
165 |
211.10 |
0.78 (0.67, 0.91) |
| Hodgkin |
23 |
25.86 |
0.89 (0.56, 1.33) |
24 |
25.03 |
0.96 (0.61, 1.43) |
| NHL** |
68 |
87.56 |
0.78 (0.60, 0.98) |
58 |
85.50 |
0.68 (0.52, 0.88) |
| Multiple myeloma |
12 |
16.26 |
0.74 (0.38, 1.29) |
17 |
16.13 |
1.05 (0.61, 1.69) |
| Leukemias |
64 |
86.26 |
0.74 (0.57, 0.95) |
66 |
84.43 |
0.78 (0.60, 0.99) |
| Cervical cancer |
2 |
3.53 |
0.57 (0.07, 2.05) |
5 |
4.88 |
1.03 (0.33, 2.39) |
|
Diseases of secondary interest | ||||||
| Pancreatic cancer |
44 |
60.05 |
0.73 (0.53, 0.98) |
57 |
58.29 |
0.98 (0.74, 1.27) |
| Colon cancer |
73 |
93.28 |
0.78 (0.61, 0.98) |
86 |
92.29 |
0.93 (0.75, 1.15) |
| Rectal cancer |
16 |
29.84 |
0.54 (0.31, 0.87) |
24 |
29.54 |
0.81 (0.52, 1.21) |
| Soft tissue cancers |
21 |
27.82 |
0.75 (0.47, 1.15) |
29 |
27.44 |
1.06 (0.71, 1.52) |
| Brain cancer |
80 |
93.36 |
0.86 (0.68, 1.07) |
74 |
88.95 |
0.83 (0.65, 1.04) |
| Laryngeal cancer |
13 |
12.15 |
1.07 (0.57, 1.83) |
6 |
11.92 |
0.50 (0.18, 1.10) |
| Lung*** cancer |
216 |
265.44 |
0.81 (0.71, 0.93) |
237 |
259.01 |
0.92 (0.80, 1.04) |
| Oral cancers**** |
35 |
37.64 |
0.93 (0.65, 1.29) |
26 |
37.38 |
0.70 (0.45, 1.02) |
| Breast (female) cancer |
7 |
14.68 |
0.48 (0.19, 0.98) |
10 |
19.62 |
0.51 (0.24, 0.94) |
| Prostate cancer |
15 |
10.68 |
1.41 (0.79, 2.32) |
18 |
10.41 |
1.73 (1.02, 2.73) |
| Liver diseases |
233 |
322.70 |
0.72 (0.63, 0.82) |
191 |
311.90 |
0.61 (0.53, 0.71) |
| Kidney diseases |
37 |
71.72 |
0.52 (0.37, 0.71) |
37 |
74.54 |
0.50 (0.35, 0.68) |
| ALS |
27 |
19.42 |
1.39 (0.92, 2.02) |
21 |
18.45 |
1.14 (0.70, 1.74) |
| Multiple sclerosis |
10 |
14.95 |
0.67 (0.32, 1.23) |
12 |
14.75 |
0.81 (0.42, 1.42) |
|
Smoking-related diseases (not known to be related to solvent exposure) | ||||||
| Stomach cancer |
29 |
41.43 |
0.70 (0.47, 1.01) |
35 |
41.88 |
0.84 (0.58, 1.16) |
| Cardiovascular disease† |
1,376 |
1,791 |
0.77 (0.73, 0.81) |
1,390 |
1,781 |
0.78 (0.74, 0.82) |
| COPD | 45 | 55.82 | 0.81 (0.59, 1.08) | 47 | 53.89 | 0.87 (0.64, 1.16) |
Not evaluated due to small numbers were Parkinson’s disease and male breast cancer.
*Biliary passages, liver and gall bladder **Non-Hodgkin lymphoma.
***Trachea, bronchus, and lung ****Oral cavity and Pharynx.
†Includes diseases of the heart and other diseases of the circulatory system.
Camp Lejeune = 154,932; person-years = 4,140,042.
Camp Pendleton = 154,969; person-years = 4,190,132.